SBIR Phase I: A device to rapidly suture incisions from laparoscopic surgery .

该小型企业创新研究第1阶段项目旨在开发一种设备，以可靠和安全地关闭腹腔镜端口。腹腔镜检查正在成为所有腹部手术的金标准。 腹腔镜检查需要在腹壁上做小切口以允许进入腹腔。 这些小切口由于其尺寸和患者的尺寸而非常难以闭合。 如果尝试关闭不良或这些端口未关闭，则患者发生危及生命的并发症的风险增加。 Surg Solutions建议开发一种设备，可以在30秒内可靠安全地关闭这些端口。 第一阶段项目的目标是重新设计可制造性的早期概念原型，进行台架测试和动物测试。该项目更广泛的影响/商业潜力是减少与闭合腹腔镜手术切口相关的特定并发症。 腹腔镜手术的一个经常被忽视的组成部分是进入部位。 如果没有正确关闭或保持打开状态，患者发生危及生命的并发症的风险会增加。 这些并发症会影响患者，并最终从治疗和诉讼的角度花费医疗保健系统大量资金。 目前还没有关闭这些港口的良好技术或手段。 如果成功，这项技术可能成为关闭港口的首选程序，市场潜力为4亿美元。此外，该设备可能会降低医疗保健系统的成本，并改善接受择期手术的患者的生活质量。

This Small Business Innovation Research Phase 1 project aims to develop a device to reliably and safely close laparoscopic port sites. Laparoscopy is becoming the gold standard for all abdominal procedures. Laparoscopy requires small incisions to be made in the abdominal wall to allow access to the abdominal cavity. These small incisions are extremely difficult and frustrating to close due to their size and the size of the patient. If a poor closure is attempted or these ports are not closed, the patient is placed at increased risk of developing life threatening complications. Surg Solutions proposes to develop a device to reliably and safely close these port sites in 30 seconds. The goals of this phase 1 project are to redesign an early-concept prototype for manufacturability, to perform bench testing and animal testing.The broader impact/commercial potential of this project is to reduce the specific complications associated with closing laparoscopic surgical incisions. One component of laparoscopic procedures that is often overlooked is the access sites. If not closed properly or left open, the patient is at increased risk for life threatening complications. These complications impact the patient and end up costing the health care system a significant amount of money from a treatment and litigation standpoint. Currently there are no good techniques or instruments available to close these port sites. If successful, this technology could become a preferred procedure for closing port sites with a market potential of $400 million. In addition, this device could potentially reduce the cost to the health care system and improve the quality of life of patients undergoing elective surgery.